• Improving In Vitro Drug Response Evaluation in Cancer Resear

  2026-06-01

  Schwartz’s dissertation presents a critical advance in in vitro drug response assessment by separating proliferative arrest from cell death, revealing that these processes are distinct and often occur in different proportions and timing. This insight enables more precise evaluation of anti-cancer compounds and suggests new directions for optimizing experimental drug screening protocols.

• GSK621 (SKU B6020): Reliable AMPK Agonist for AML & Metaboli

  2026-05-31

  This article delivers scenario-based guidance for using GSK621 (SKU B6020) as a potent, specific AMPK agonist in acute myeloid leukemia (AML) and immunometabolic research. By addressing protocol optimization, data interpretation, and vendor selection, it equips life science researchers with evidence-backed strategies to enhance assay reproducibility and data integrity.

• NUAK1 Inhibition Lowers Pathogenic Tau Ser356 in Alzheimer’s

  2026-05-30

  Taylor et al. (2023) demonstrate that phosphorylation of tau at Ser356—a process mediated by NUAK1—is closely associated with Alzheimer’s disease progression and neurofibrillary tangle pathology. Using the NUAK1/2 inhibitor WZ4003, the study reveals that targeted NUAK inhibition reduces pathogenic p-tau Ser356 in both mouse and human brain slice cultures, offering mechanistic insight for future therapeutic strategies in neurodegenerative disease research.

• Pravastatin Sodium in Translational Research: Beyond Cholest

  2026-05-29

  Explore how Pravastatin sodium, a potent HMG-CoA reductase inhibitor, advances translational biomedical research by enabling precise cholesterol biosynthesis inhibition and uncovering new applications in metabolic and tumor biology. This article provides a mechanistic, protocol-driven analysis you will not find elsewhere.

• Niclosamide: Advanced STAT3 Inhibition in Leukemia Models

  2026-05-29

  Explore how Niclosamide, a small-molecule STAT3 inhibitor, enables advanced mechanistic research in acute myelogenous leukemia models. This article uniquely connects its molecular action to comparative assay design and plant-derived alternatives, offering critical insights for cancer researchers.

• Panobinostat Disrupts Epigenetic Maintenance in MLL-ALL Mode

  2026-05-28

  This study demonstrates that panobinostat, a broad-spectrum histone deacetylase inhibitor, exerts potent anti-leukaemic effects in vivo against MLL-rearranged acute lymphoblastic leukaemia (ALL) by disrupting the RNF20/RNF40/WAC-H2B ubiquitination axis. The findings highlight a novel mechanistic vulnerability in MLL-ALL and provide a rational basis for future epigenetic therapy development.

• Cyclo (-RGDfC) in High-Throughput Tumor Targeting Assays

  2026-05-28

  Cyclo (-RGDfC) empowers advanced cancer and angiogenesis research through precise, reproducible αvβ3 integrin targeting. Its cyclic structure and high affinity enable robust results in high-throughput hydrogel and cell adhesion workflows, especially when paired with modern digital light printing platforms.

• HyperFusion™: High-Fidelity DNA Polymerase for Precise PCR

  2026-05-27

  HyperFusion™ high-fidelity DNA polymerase offers over 50-fold greater fidelity than Taq polymerase and robust amplification of GC-rich or long templates. This proofreading DNA polymerase is engineered for accuracy, speed, and inhibitor tolerance, making it ideal for applications such as cloning and high-throughput sequencing. APExBIO’s enzyme sets a new benchmark for reproducible, reliable PCR workflows.

• Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301): P

  2026-05-27

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) offer efficient and specific capture of biotinylated molecules, streamlining purification and immunoprecipitation workflows in molecular biology. They are optimal for applications requiring high-affinity binding and low nonspecific background, but are not suited for use with non-biotinylated targets or in workflows sensitive to bovine serum albumin or sodium azide.

• Laminin (925-933): Mechanistic Precision in Translational Re

  2026-05-26

  Laminin (925-933), a synthetic peptide from the laminin B1 chain, is redefining how translational researchers approach cell adhesion and migration studies. By emulating a critical extracellular matrix domain, this tool offers unmatched specificity for cell adhesion and chemotaxis assays—enabling precise modeling of metastasis and tissue remodeling. This article synthesizes mechanistic insights, evidence-based guidance, and strategic foresight, serving as a blueprint for leveraging Laminin (925-933) in advanced translational workflows.

• Novel Antifungal Strategies Against Candida auris: Systemati

  2026-05-26

  This systematic review synthesizes the latest antifungal pipeline developments targeting multidrug-resistant Candida auris. Emphasizing investigational agents with novel mechanisms, the study highlights the urgent need for new therapies and provides comparative data on efficacy and selectivity relevant for translational research.

• NLRP3 Inflammasome and Coagulation in Endotoxemic Mice: New

  2026-05-25

  This study delineates the distinct contributions of TLR4, caspase-11, and the NLRP3 inflammasome to the release of tissue factor-positive extracellular vesicles (EVs) and coagulation activation in a mouse model of endotoxemia. The findings clarify that while TLR4 is the primary driver of coagulation, caspase-11 and NLRP3 have more limited, time-dependent roles, refining the mechanistic understanding of coagulation in sepsis and informing targeted research strategies.

• Selective Nanomolar IRAP Inhibitors via α-Hydroxy-β-Amino Be

  2026-05-25

  This study presents a highly selective, nanomolar inhibitor of insulin-regulated aminopeptidase (IRAP) based on a synthetic α-hydroxy-β-amino acid scaffold derived from bestatin. Through regio- and stereoselective functionalization and structural analysis, the work advances both inhibitor design and mechanistic understanding, providing new chemical tools for probing M1 zinc aminopeptidases.

• 10074-G5: Advanced c-Myc Inhibitor Workflows in Cancer Resea

  2026-05-24

  10074-G5 enables precise disruption of c-Myc/Max dimerization, empowering next-generation cancer research assays. This guide delivers protocol-driven insights, troubleshooting strategies, and direct applications for apoptosis, cell cycle arrest, and tumor regression studies.

• MAPK10 Regulates NSCLC Metastasis via KRT16 Ubiquitination

  2026-05-23

  This study reveals that mitogen-activated protein kinase 10 (MAPK10) suppresses non-small cell lung cancer (NSCLC) metastasis by promoting phosphorylation-dependent ubiquitination and degradation of keratin 16 (KRT16). These findings define a novel MAPK10/KRT16/RNF213 axis with significant implications for biomarker discovery and targeted intervention in NSCLC.

16041 records 1/1070 page Next 12345 下5页 Last page